HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

bromelain protease F9

selectively decreases the CD44-mediated binding of peripheral blood lymphocytes (PBL) to human umbilical vein endothelial cells (HUVEC)

Also Known As:

F9 bromelain protease; bromelain F9

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Hydrolases: 2166
    - Peptide Hydrolases: 23957
      - Cysteine Proteases: 1964
        Cysteine Endopeptidases: 4
        Bromelains: 457
        bromelain protease F9: 1
      - Endopeptidases: 633
        Cysteine Endopeptidases: 4
        Bromelains: 457
        bromelain protease F9: 1

Related Diseases

1.

Melanoma (Melanoma, Malignant)

08/01/1997 - "In vitro treatment of the melanoma cells with bromelain F9 and papain before i.v. injection into mice prevented lung colonization. "
08/01/1997 - "This study examined the in vitro effects of crude bromelain, bromelain F9 and papain on B16F10 mouse melanoma cell lung colonization, in vitro cell proliferation, invasion through matrigel and CD44 expression. "
08/01/1997 - "Using flow cytometry, the proteases were found to reduce the CD44 density, present on the melanoma cells, to a different degree: crude bromelain was more active than bromelain F9 and papain, which had higher proteolytic activity. "

Related Drugs and Biologics

1.	Papain
2.	Bromelains (Bromelain)
3.	matrigel
4.	Peptide Hydrolases (Proteases)